Bluestar Genomics Appoints David Mullarkey Chief Executive Officer
Samuel Levy to continue as Chief Scientific Officer ...
Stay updated with breaking news from Dow Pharmaceutical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Samuel Levy to continue as Chief Scientific Officer ...
On Thursday, the Federal Circuit issued an opinion resolving the question of where venue is proper for patent infringement claims brought pursuant to the
Pharmaceuticals your username November 6, 2020 On Thursday, the Federal Circuit issued an opinion resolving the question of where venue is proper for patent infringement claims brought pursuant to the Hatch-Waxman Act. The court largely affirmed the findings of the trial court in favor of the defendant-appellees, sued by other pharmaceutical manufacturers for allegedly infringing on patents related to the toenail fungus infection treatment Jublia. The case was brought by Valeant Pharmaceuticals North America LLC, Valeant Pharmaceuticals Ireland Ltd., Dow Pharmaceutical Sciences, Inc., and Kak...